NAF PLUS
Google image searchProduct monograph
Active ingredient
sodium fluoride f 18, 7400 MBq/ML
DIN: 02402017
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Schedule: Schedule C
Company: ISOLOGIC INNOVATIVE RADIOPHARMACEUTICALS LTD.
Date: 13-AUG-2018
ATC:
- V09 — DIAGNOSTIC RADIOPHARMACEUTICALS (ATC, ATC/DDD, )
- V09I — TUMOUR DETECTION (ATC, ATC/DDD)
- V09IX — Other diagnostic radiopharmaceuticals for tumour detection (ATC, ATC/DDD)
- V09IX04 — FLUDEOXYGLUCOSE (18F) (ATC/DDD)
Pharmaceutical standard: USP
